Stathmin 1產(chǎn)品信息
英文名稱:Stathmin
中文名稱:Stathmin蛋白
靶點(diǎn)別稱:STMN1,Stathmin 1,C1orf215,LAP18,OP18
物種:Human
標(biāo)簽:His Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human Stathmin 1, His Tag (ST1-H5149) is expressed from E. coli cells. It contains AA Ala 2 - Asp 149 (Accession # NP_981946).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 18.1 kDa. The protein migrates as 18 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Stathmin(STMN1)是Stathmin家族的成員,也被稱為白血病相關(guān)磷蛋白p18、癌蛋白18(Op18)、磷蛋白p19(pp19)、蛋白Pr22和pp17,其中含有一個(gè)SLD(Stathmin樣)結(jié)構(gòu)域。STMN1作為微管動力學(xué)的重要調(diào)節(jié)蛋白的功能已得到很好的表征。Stathmin(STMN1)與兩個(gè)二聚體α,β-微管蛋白分子相互作用,形成一個(gè)緊密的三元復(fù)合物,稱為T2S復(fù)合物。一摩爾STMN1通過stathmin樣結(jié)構(gòu)域(SLD)與兩摩爾微管蛋白二聚體結(jié)合。當(dāng)STMN1將微管蛋白螯合到T2S復(fù)合物中時(shí),微管蛋白變得不可聚合。沒有微管蛋白聚合,就沒有微管組裝。STMN1還通過直接作用于微管末端來促進(jìn)微管解體。
關(guān)鍵字: Stathmin;Stathmin蛋白;STMN1重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。